Event Concluded

TechDogs-"Meeting the Container Closure Integrity Requirements in the Revised EU Annex 1: A Science-Based Holistic Approach"

Pharmaceutical Technology

Meeting the Container Closure Integrity Requirements in the Revised EU Annex 1: A Science-Based Holistic Approach

By PharmTech

PharmTech
Overall Rating

About Event

The revision of EU GMP Annex 1, Manufacture of Sterile Medicinal Products, was finalized on August 25, 2022, and includes new requirements for ensuring the container closure integrity (CCI) of sterile pharmaceutical products. This webinar will present how sterile product manufacturers can prepare themselves for the new regulations using a science-based holistic approach to ensure good CCI, and includes a description of CCIT methods that can be used for frozen products needing cold chain storage and transport. Key Learning Objectives Learn in detail how the new requirements of the revised EU Annex 1 may impact your strategy for ensuring the container closure integrity of sterile pharmaceutical products. Gain understanding of the advantages and disadvantages of container closure integrity (CCI) testing methods and why a science-based holistic approach to ensure good CCI is important. Learn how cold chain storage and transport can impact the container closure integrity of sterile pharmaceutical products.
Register

Join The Discussion

Join Our Newsletter

Get weekly news, engaging articles, and career tips-all free!

By subscribing to our newsletter, you're cool with our terms and conditions and agree to our Privacy Policy.

  • Dark
  • Light